Showing results (1941-1950 of 6,739) with videos related to
Sort By:
Pageof 674
Oncotargets and Therapy|October 20, 2022
Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year After Standard TreatmentChengqi Yu, Leilei Jiang, Dan Yang, et al.Oncotargets and Therapy|October 21, 2022
ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature ReviewQinchuan Yu, Zhiqiang Zhao, He Wang, et al.Oncotargets and Therapy|October 14, 2022
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent ChemoradiotherapyChia-Lin Chou, Tzu-Ju Chen, Wan-Shan Li, et al.Oncotargets and Therapy|October 14, 2022
Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to GemcitabineRyan N Fuller, Janviere Kabagwira, Paul A Vallejos, et al.Oncotargets and Therapy|October 28, 2022
Erratum: Snake Venom Causes Apoptosis by Increasing the Reactive Oxygen Species in Colorectal and Breast Cancer Cell Lines [Corrigendum]Oncotargets and Therapy|October 24, 2022
CCNB1 Expedites the Progression of Cervical Squamous Cell Carcinoma via the Regulation by FOXM1 [Retraction]Oncotargets and Therapy|October 24, 2022
Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction]Oncotargets and Therapy|October 24, 2022
Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction]Oncotargets and Therapy|October 24, 2022
Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of NivolumabRyan S Chiang, Michael J Glover, Ali Raza Khaki, et al.Oncotargets and Therapy|October 3, 2022
Cetuximab and Dabrafenib Plus Trametinib for Untreated Colonic Metastasis of BRAFV600E Mutant Primary Lung Adenocarcinoma with Signet Ring Cell Features: An Interesting and Rare Case ReportShujun Jiang, Yanran Wu, Wenjie Wei, et al.Pageof 674